{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:07:20Z","timestamp":1774926440763,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.radonc.2022.02.030","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T11:18:26Z","timestamp":1646392706000},"page":"64-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors: A systematic review of the literature"],"prefix":"10.1016","volume":"170","author":[{"given":"Willeke","family":"Danckaert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Spaas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrien","family":"Vandecasteele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"De Wagter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piet","family":"Ost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2022.02.030_b0005","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1002\/mp.12462","article-title":"AAPM TG 158: Measurement and calculation of doses outside the treated volume from external-beam radiation therapy","volume":"44","author":"Kry","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2022.02.030_b0010","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/path.1700640403","article-title":"The sensitivity of lymphocytes to ionising radiation","volume":"64","author":"Trowell","year":"1952","journal-title":"J Pathol Bacteriol"},{"key":"10.1016\/j.radonc.2022.02.030_b0015","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2307\/3577549","article-title":"Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay","volume":"123","author":"Nakamura","year":"1990","journal-title":"Radiat Res"},{"key":"10.1016\/j.radonc.2022.02.030_b0020","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0360-3016(94)00430-S","article-title":"Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy","volume":"31","author":"Mauch","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.02.030_b0025","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ijrobp.2009.11.040","article-title":"Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging","volume":"79","author":"Hayman","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.02.030_b0030","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/1097-0142(197309)32:3<699::AID-CNCR2820320324>3.0.CO;2-V","article-title":"Bone marrow regeneration and extension after extended field irradiation in Hodgkin's disease","volume":"32","author":"Rubin","year":"1973","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2022.02.030_b0035","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41571-019-0238-9","article-title":"Assessing the interactions between radiotherapy and antitumour immunity","volume":"16","author":"Grassberger","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2022.02.030_b0040","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ijrobp.2019.08.047","article-title":"Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer","volume":"105","author":"Cho","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.02.030_b0045","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;372:n71.","DOI":"10.1136\/bmj.n71"},{"key":"10.1016\/j.radonc.2022.02.030_b0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.radonc.2022.02.030_b0055","unstructured":"GA Wells BS, D O'Connell, J Peterson, V Welch, M Losos and P Tugwell. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. 2011."},{"key":"10.1016\/j.radonc.2022.02.030_b0060","series-title":"Quality Improvement Interventions To Address Health Disparities. Evidence Report\/ technology Assessment","author":"McPheeters","year":"2012"},{"key":"10.1016\/j.radonc.2022.02.030_b0065","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ijrobp.2016.01.022","article-title":"Hematologic Toxicity in Patients Treated With Postprostatectomy Whole- Pelvis Irradiation With Different Intensity Modulated Radiation Therapy Techniques Is Not Negligible and Is Prolonged: Preliminary Results of a Longitudinal, Observational Study","volume":"95","author":"Cozzarini","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.02.030_b0070","doi-asserted-by":"crossref","unstructured":"Eckert F, Schaedle P, Zips D, Schmid-Horch B, Rammensee HG, Gani C, et al. Impact of curative radiotherapy on the immune status of patients with localized prostate cancer. Oncoimmunology. 2018;7:e1496881.","DOI":"10.1080\/2162402X.2018.1496881"},{"key":"10.1016\/j.radonc.2022.02.030_b0075","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1017\/S1460396908006444","article-title":"Peripheral blood lymphocyte counts during standard conformal radiotherapy and TomoTherapy\/IMRT for prostate cancer","volume":"7","author":"Elsworthy","year":"2008","journal-title":"J Radiother Pract"},{"key":"10.1016\/j.radonc.2022.02.030_b0080","first-page":"2803","article-title":"Hematologic toxicity of conformal radiotherapy and intensity modulated radiotherapy in prostate and bladder cancer patients","volume":"19","author":"Miszczyk","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.radonc.2022.02.030_b0085","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2217\/fon.13.237","article-title":"Hematologic changes during prostate cancer radiation therapy are dependent on the treatment volume","volume":"10","author":"Pinkawa","year":"2014","journal-title":"Future Oncol"},{"key":"10.1016\/j.radonc.2022.02.030_b0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.adro.2019.01.005","article-title":"Radiation-related lymphopenia after pelvic nodal irradiation for prostate cancer","volume":"4","author":"Schad","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.02.030_b0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.radonc.2015.11.020","article-title":"Dose-volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation","volume":"118","author":"Sini","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.02.030_b0100","doi-asserted-by":"crossref","first-page":"26422","DOI":"10.18632\/oncotarget.8389","article-title":"Peripheral lymphocyte subset variation predicts prostate cancer carbon ion radiotherapy outcomes","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2022.02.030_b0105","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ijrobp.2006.03.018","article-title":"Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy","volume":"66","author":"Mell","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.radonc.2022.02.030_b0110","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/EDE.0000000000000678","article-title":"Androgen Deprivation Therapy and the Risk of Anemia in Men with Prostate Cancer","volume":"28","author":"Hicks","year":"2017","journal-title":"Epidemiology"},{"key":"10.1016\/j.radonc.2022.02.030_b0115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","volume":"123","author":"Venkatesulu","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"issue":"13","key":"10.1016\/j.radonc.2022.02.030_b0120","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1158\/0008-5472.CAN-08-3845","article-title":"Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas","volume":"69","author":"Ray-Coquard","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2022.02.030_b0125","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.urolonc.2010.08.009","article-title":"Prognostic relevance of preoperative circulating CD8-positive lymphocytes in the urinary bladder recurrence of urothelial carcinoma","volume":"30","author":"Lin","year":"2012","journal-title":"Urol Oncol"},{"key":"10.1016\/j.radonc.2022.02.030_b0130","first-page":"840","article-title":"Clinical status and rate of recovery of blood lymphocyte levels after radiotherapy for bladder cancer","volume":"39","author":"O'Toole","year":"1979","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2022.02.030_b0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.euo.2018.09.013","article-title":"Combining immunotherapy with radiotherapy for the treatment of genitourinary malignancies","volume":"2","author":"Solanki","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.radonc.2022.02.030_b0140","doi-asserted-by":"crossref","first-page":"S590","DOI":"10.1016\/j.annonc.2020.08.837","article-title":"Predicting survival in urothelial cancer patients after immunotherapy using real-world data","volume":"31","author":"Elumalai","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2022.02.030_b0145","doi-asserted-by":"crossref","first-page":"15387","DOI":"10.1038\/s41598-017-15673-2","article-title":"The Prognostic Value of Platelet-to-Lymphocyte Ratio in Urological Cancers: A Meta-Analysis","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2022.02.030_b0150","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001670","article-title":"Pretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors: A Systematic Review and Meta-Analysis","volume":"94","author":"Luo","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.radonc.2022.02.030_b0155","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41585-019-0213-3","article-title":"New approaches for effective and safe pelvic radiotherapy in high-risk prostate cancer","volume":"16","author":"Tharmalingam","year":"2019","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.radonc.2022.02.030_b0160","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/1097-0142(197809)42:3<1057::AID-CNCR2820420304>3.0.CO;2-P","article-title":"Bone marrow regeneration following large field radiation: influence of volume, age, dose, and time","volume":"42","author":"Sacks","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2022.02.030_b0165","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/07357907.2012.762780","article-title":"The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells","volume":"31","author":"Yovino","year":"2013","journal-title":"Cancer Invest"},{"key":"10.1016\/j.radonc.2022.02.030_b0170","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijrobp.2016.10.046","article-title":"Does unintentional splenic radiation predict outcomes after pancreatic cancer radiation therapy?","volume":"97","author":"Chadha","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.02.030_b0175","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijrobp.2019.05.064","article-title":"Impact of radiation dose to the host immune system on tumor control and survival for stage III non-small cell lung cancer treated with definitive radiation therapy","volume":"105","author":"Ladbury","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.02.030_b0180","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac16ea","article-title":"HEDOS-a computational tool to assess radiation dose to circulating blood cells during external beam radiotherapy based on whole-body blood flow simulations","volume":"66","author":"Shin","year":"2021","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2022.02.030_b0185","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.semradonc.2019.12.003","article-title":"Lymphocyte-sparing radiotherapy: the rationale for protecting lymphocyte-rich organs when combining radiotherapy with immunotherapy","volume":"30","author":"Lambin","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.02.030_b0190","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ijrobp.2015.11.026","article-title":"Lymphocyte-sparing effect of stereotactic body radiation therapy in patients with unresectable pancreatic cancer","volume":"94","author":"Wild","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.02.030_b0195","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ijrobp.2019.07.013","article-title":"Lymphocyte count kinetics, factors associated with the end-of-radiation- therapy lymphocyte count, and risk of infection in patients with solid malignant tumors treated with curative-intent radiation therapy","volume":"105","author":"Terrones-Campos","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.02.030_b0200","doi-asserted-by":"crossref","unstructured":"D\u00f6rr W. Pathogenesis of normal-tissue side-effects. Basic Clinical Radiobiology. Fourth ed: Taylor & Francis Ltd; 2009. p. 179-81.","DOI":"10.1201\/b13224-14"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022001153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022001153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:20:25Z","timestamp":1759123225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814022001153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":40,"alternative-id":["S0167814022001153"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2022.02.030","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors: A systematic review of the literature","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2022.02.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}